$NMRA

$0.39 +$0.01 (3.56%) Close

$NMRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$NMRA Management Team

Mr. Jason Duncan

Chief Legal and Administrative Officer

Age 51

Compensation $4.120M USD

Sex Male

Dr. Joshua Pinto

President

Age 41

Compensation $3.822M USD

Sex Male

Mr. Michael Milligan

Chief Financial Officer

Principal Accounting Officer

Age 53

Compensation -

Sex Male

Mr. Paul Berns

Chairman of the Board

Chief Executive Officer

Co-Founder

Age 58

Compensation $8.648M USD

Sex Male

Dr. Daljit Aurora

Chief Operating and Development Officer

Age 58

Compensation $5.202M USD

Sex Male

Ms. Helen Rubinstein

IR Contact Officer

Age -

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Jason Duncan Chief Legal and Administrative Officer	51	$4.120M USD	Male
Dr. Joshua Pinto President	41	$3.822M USD	Male
Mr. Michael Milligan Chief Financial Officer Principal Accounting Officer	53	-	Male
Mr. Paul Berns Chairman of the Board Chief Executive Officer Co-Founder	58	$8.648M USD	Male
Dr. Daljit Aurora Chief Operating and Development Officer	58	$5.202M USD	Male
Ms. Helen Rubinstein IR Contact Officer	-	-	Female

Board of Directors

From the proxy statement filed Apr 17, 2026

Directors

serving now

Independent

0 of 1

stated in the proxy; 5 not stated

Average tenure

5.0 years

from year joined

CEO also chairs the board

Yes

Paul L. Berns

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Paul L. Berns Board chair, CEO	59	2020 6 years	Not independent	None stated	None stated	Paid as CEO
Matthew Fust	61	2020 6 years	Not stated	None stated	None stated	$134,257
David Piacquad	69	2023 3 years	Not stated	Audit Committee	None stated	$97,382
Kristina Burow	52	2020 6 years	Not stated	None stated	Boundless Bio, Beam Therapeutics, Scholar Rock	$111,132
Alaa Halawa	43	2022 4 years	Not stated	None stated	None stated	$106,132
Maykin Ho	73	2021 5 years	Not stated	Audit Committee	Agios Pharmaceuticals, BioMarin Pharmaceutical, FibroGen	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 17, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$NMRA Management Team

Mr. Jason Duncan

Dr. Joshua Pinto

Mr. Michael Milligan

Mr. Paul Berns

Dr. Daljit Aurora

Ms. Helen Rubinstein

Board of Directors

Related-party transactions

No related-party transactions disclosed